5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion (Q77530946)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9808259%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

title

5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9808259%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

Ninan I

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9808259%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Kulkarni SK

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9808259%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9808259%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9808259%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

358

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9808259%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9808259%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

111-116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9808259%20AND%20SRC:MED&resulttype=core&format=json

The receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

Association between clozapine response and allelic variation in 5-HT2A receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

The selective 5-HT2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse--implications for psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

The efficacy of the D2 and 5-HT2 antagonist risperidone (R 64,766) in the treatment of chronic psychosis. An open dose-finding study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

Effect of serotonin antagonism in schizophrenia: a pilot study with setoperone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

On the mode of action of apomorphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

Effects of the 5-HT2 receptor antagonist, ritanserin, on biogenic amines in the rat nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

Effects of the novel 5-HT1A receptor antagonist, (+)-WAY 100135, on stereotyped behaviour induced by the NMDA receptor antagonist dizocilpine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

Serotonergic involvement in phencyclidine-induced behaviors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

Serotonin (5-HT2) receptor mediated enhancement of cortical unit activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900591-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(98)00591-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9808259%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference